146 related articles for article (PubMed ID: 32456488)
1. The effects of exogenous oral micronized progesterone on first trimester aneuploidy screening markers in women with threatened miscarriage: a matched case control study.
Karaca I; Erdoğan ŞV; Doğan K; Alay I; Ince O; Yıldırım Karaca S; Comba C; Bahceci E; Erdoğan A; Ozturk E; Ekin M
J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1224-1229. PubMed ID: 32456488
[TBL] [Abstract][Full Text] [Related]
2. The effects of progesterone treatment on nuchal translucency in women with threatened miscarriage.
Karadağ C; Yoldemir T; Demircan S; Çalışkan E
J Obstet Gynaecol; 2021 May; 41(4):601-604. PubMed ID: 32811232
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
4. Early vaginal bleeding has no impact on markers used in first trimester aneuploidy screening.
Spencer K; Spencer CE; Stamatopoulou A; Staboulidou I; Nicolaides KH
Prenat Diagn; 2010 Jun; 30(6):547-50. PubMed ID: 20509154
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
[TBL] [Abstract][Full Text] [Related]
6. The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy.
Ziolkowska K; Dydowicz P; Sobkowski M; Tobola-Wrobel K; Wysocka E; Pietryga M
Ginekol Pol; 2019; 90(3):161-166. PubMed ID: 30950006
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].
Borowski D; Czuba B; Cnota W; Hincz P; Czekierdowski A; Gajewska J; Jaczyńska R; Ceran A; Włoch A; Wyrwas D; Wiełgoś M; Szymusik I; Szaflik K; Sodowski K
Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331
[TBL] [Abstract][Full Text] [Related]
8. First-trimester markers of aneuploidy in women positive for HIV.
Savvidou MD; Samuel I; Syngelaki A; Poulton M; Nicolaides KH
BJOG; 2011 Jun; 118(7):844-8. PubMed ID: 21062401
[TBL] [Abstract][Full Text] [Related]
9. Does vaginal bleeding influence first-trimester markers for Down syndrome?
Heinig J; Steinhard J; Schmitz R; Nofer JR; Witteler R; Mosel A; Ahrens A; Kiesel L; Klockenbusch W
Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
[TBL] [Abstract][Full Text] [Related]
10. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
11. The significance of maternal blood pregnancy-associated plasma protein A (PAPP-A) and free beta-subunit of human chorionic gonadotropin (β-hCG) levels for the risk assessment of fetal trisomy 18 during the first prenatal testing between 11 and 13+6 weeks of pregnancy.
Ziolkowska K; Tobola-Wrobel K; Dydowicz P; Zurawski S; Pietryga M; Wysocka E
Ginekol Pol; 2020; 91(12):748-754. PubMed ID: 33447994
[TBL] [Abstract][Full Text] [Related]
12. The effect of maternal polycystic ovary morphology on first-trimester maternal serum biochemical markers of aneuploidy and fetal nuchal translucency thickness.
Hacivelioglu S; Uysal A; Gungor AN; Gencer M; Cakir DU; Cosar E
Clin Exp Obstet Gynecol; 2015; 42(1):32-5. PubMed ID: 25864278
[TBL] [Abstract][Full Text] [Related]
13. The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage.
Yıldız E; Timur B
Turk J Obstet Gynecol; 2023 Mar; 20(1):16-21. PubMed ID: 36908009
[TBL] [Abstract][Full Text] [Related]
14. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
[TBL] [Abstract][Full Text] [Related]
15. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
[TBL] [Abstract][Full Text] [Related]
16. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
Spencer K; Cowans NJ; Spencer CE; Achillea N
Prenat Diagn; 2010 Oct; 30(10):937-40. PubMed ID: 20687123
[TBL] [Abstract][Full Text] [Related]
17. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
Spencer K; Cicero S; Atzei A; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):927-9. PubMed ID: 16088864
[TBL] [Abstract][Full Text] [Related]
18. Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency.
de Graaf IM; Pajkrt E; Bilardo CM; Leschot NJ; Cuckle HS; van Lith JM
Prenat Diagn; 1999 May; 19(5):458-62. PubMed ID: 10360515
[TBL] [Abstract][Full Text] [Related]
19. First-trimester screening for trisomies in pregnancies with vanishing twin.
Chaveeva P; Wright A; Syngelaki A; Konstantinidou L; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):326-331. PubMed ID: 31710734
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
